Logo

Nanosphere Raises $35.3M in Public Offering

Oct 22, 2009

NEW YORK (GenomeWeb News) – Nanosphere has closed a public offering of its common stock, raising approximately $35.3 million.

The Northbrook, Ill.-based molecular diagnostics firm sold 5,405,000 shares of common stock at a price of $7 per share. The total number of shares sold includes 705,000 shares that comprised the over-allotment option.

Nanosphere said that it will use the proceeds for general corporate purposes and working capital.

Filed under

Diagnostics
Business News
stock offering
Luminex
Breaking News
The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.